Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1448256071
总结
TPMT *1/*3A is associated with increased likelihood of dose reduction when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to TPMT *1/*1.